ASSOCIATION OF ADIPONECTIN +45 T/G POLYMORPHISM WITH THE RISK OF POLYCYSTIC OVARY SYNDROME IN WOMEN FROM WEST AZERBAIJAN PROVINCE, IRAN

Polycystic ovary syndrome is the most common cause of infertility and is characterized by the lack of ovulation and hyperandrogenism. The prevalence of polycystic ovary syndrome among Iranian women is 14.6%. Several polycystic ovary syndrome susceptible gene variants have been identified so far. The results of various studies are inconsistent. Due to drug side effects and high cost of treatment, this study was designed to manage patients. In this study, the association of adiponectin +45 T/G polymorphism with the risk of polycystic ovary syndrome in women from West Azerbaijan Province (Iran) was evaluated.

This study was performed in two groups of patients and controls. 3 ml of peripheral blood was collected from the participants in the study. Saturated salt method was used to extract genomic DNA. PCR-RFLP method was used to determine polymorphisms.

The mean age of the participants was 25.03±3.6 in the patient group and 27.01 ± 4.8 in the control group. All the patients who participated in this study had average obesity with a body mass index of 26.04±3.9. All patients were hirsute. In this study, no significant differences were observed between the case and control groups regarding genotypic and allelic frequencies. The observed alleles and genotypes of ADIPOQ +45 (T / G) were in Hardy-Weinberg equilibrium in the control group. Chi-square and p-values with two degrees of freedom are 3.2 (<3.84) and 0.1, respectively.

ADIPOQ +45 (T / G) gene polymorphism is not a risk factor for polycystic ovary syndrome in women of West Azerbaijan Province. Investigation of other risk factors related to genetic and environmental factors and their interaction with each other is recommended.